Drug intelligence / Profile preview

MEPHAJOY-P

Development stage
Unknown
Lead developer
JoY Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

MEPHAJOY-P is a fixed-dose combination pharmaceutical product marketed by JoY Pharma, primarily used for its anti-inflammatory, analgesic, and antipyretic properties. It contains mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID) of the fenamate class, and paracetamol (acetaminophen). Mefenamic acid works by inhibiting the cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the production of prostaglandins that mediate pain and inflammation. Paracetamol provides complementary analgesic and antipyretic effects, likely through the inhibition of prostaglandin synthesis within the central nervous system. This combination is commonly used in clinical practice for the symptomatic relief of mild to moderate pain, including dental pain, muscle aches, and dysmenorrhea, as well as for the management of fever. It is marketed as a branded generic in India.

Brand names
MEPHAJOY-P
Other names
mefenamic acid + paracetamolmefenamic acid and paracetamol
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on MEPHAJOY-P.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MEPHAJOY-P.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call